248 related articles for article (PubMed ID: 16969279)
1. No association of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia.
Philibert R; Gunter T; Hollenbeck N; Adams WJ; Bohle P; Packer H; Sandhu H
Psychiatr Genet; 2006 Oct; 16(5):221-3. PubMed ID: 16969279
[TBL] [Abstract][Full Text] [Related]
2. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies.
Zintzaras E
Psychiatr Genet; 2006 Jun; 16(3):105-15. PubMed ID: 16691128
[TBL] [Abstract][Full Text] [Related]
3. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women.
Sazci A; Ergul E; Kucukali I; Kara I; Kaya G
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1113-23. PubMed ID: 16084002
[TBL] [Abstract][Full Text] [Related]
4. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
[TBL] [Abstract][Full Text] [Related]
5. C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas.
Kafadar AM; Yilmaz H; Kafadar D; Ergen A; Zeybek U; Bozkurt N; Kuday C; Isbir T
Anticancer Res; 2006; 26(3B):2445-9. PubMed ID: 16821630
[TBL] [Abstract][Full Text] [Related]
6. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia.
Roffman JL; Weiss AP; Purcell S; Caffalette CA; Freudenreich O; Henderson DC; Bottiglieri T; Wong DH; Halsted CH; Goff DC
Biol Psychiatry; 2008 Jan; 63(1):42-8. PubMed ID: 17543893
[TBL] [Abstract][Full Text] [Related]
7. Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population-based case-control study.
Feng LG; Song ZW; Xin F; Hu J
Psychiatry Res; 2009 Aug; 168(3):205-8. PubMed ID: 19564051
[TBL] [Abstract][Full Text] [Related]
8. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.
Muntjewerff JW; Gellekink H; den Heijer M; Hoogendoorn ML; Kahn RS; Sinke RJ; Blom HJ
Eur Neuropsychopharmacol; 2008 Feb; 18(2):99-106. PubMed ID: 17716874
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis.
Muntjewerff JW; Kahn RS; Blom HJ; den Heijer M
Mol Psychiatry; 2006 Feb; 11(2):143-9. PubMed ID: 16172608
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
Ren A; Wang J
Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
[TBL] [Abstract][Full Text] [Related]
12. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey.
Sazci A; Ergul E; Kaya G; Kara I
Cell Biochem Funct; 2005; 23(1):51-4. PubMed ID: 15386535
[TBL] [Abstract][Full Text] [Related]
13. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
14. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene in patients with essential tremor in Turkey.
Sazci A; Ergul E; Bayulkem K
Mov Disord; 2004 Dec; 19(12):1472-6. PubMed ID: 15390052
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.
Gilbody S; Lewis S; Lightfoot T
Am J Epidemiol; 2007 Jan; 165(1):1-13. PubMed ID: 17074966
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase C677T-polymorphism and its association with alcohol withdrawal seizure.
Lutz UC; Batra A; Kolb W; Machicao F; Maurer S; Köhnke MD
Alcohol Clin Exp Res; 2006 Dec; 30(12):1966-71. PubMed ID: 17117960
[TBL] [Abstract][Full Text] [Related]
17. Influence of maternal MTHFR A1298C polymorphism on the risk in offspring of schizophrenia.
Zhang C; Xie B; Fang Y; Cheng W; Du Y; Wang D; Yu S
Brain Res; 2010 Mar; 1320():130-4. PubMed ID: 20044984
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence of association between MTHFR C677T polymorphism and congenital heart disease in a TDT study design.
Pereira AC; Xavier-Neto J; Mesquita SM; Mota GF; Lopes AA; Krieger JE
Int J Cardiol; 2005 Oct; 105(1):15-8. PubMed ID: 16207540
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
[TBL] [Abstract][Full Text] [Related]
20. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.
Boccia S; Hung R; Ricciardi G; Gianfagna F; Ebert MP; Fang JY; Gao CM; Götze T; Graziano F; Lacasaña-Navarro M; Lin D; López-Carrillo L; Qiao YL; Shen H; Stolzenberg-Solomon R; Takezaki T; Weng YR; Zhang FF; van Duijn CM; Boffetta P; Taioli E
Am J Epidemiol; 2008 Mar; 167(5):505-16. PubMed ID: 18162478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
